Universitätsklinikum Göttingen

Role of brain-derived natriuretic peptide in atopic dermatitis (2018) Meng JM, Moriyama MM, Feld MF, Buddenkotte JB, Buhl TB, Szollosi AS, Zhang JZ, et al. Conference contribution Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease (2018) Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Stoerk S, Wanner C, et al. Journal article Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials (2018) Von Den Gruen JM, Hartmann A, Fietkau R, Ghadimi M, Liersch T, Hohenberger W, Weitz J, et al. Journal article Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients (2018) Satzger I, Momma M, Thoms KM, Eigentler T, Schultz E, Loquai C, Zimmer L, et al. Conference contribution Dry Mouth under Immune Checkpoint Inhibitors: an Analysis of 29 Patients from 10 German Skin Cancer Centers (2018) Hensen J, Thoms KM, Kaehler K, Gutzmer R, Zimmer L, Zacher M, Alter M, et al. Conference contribution Erratum to: Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA) (2018) Schüttler C, Buschhueter N, Doellinger C, Ebert L, Hummel M, Linde J, Prokosch HU, et al. Journal article, Erratum Requirements for a cross-location biobank IT infrastructure : Survey of stakeholder input on the establishment of a biobank network of the German Biobank Alliance (GBA) (2018) Schüttler C, Buschhueter N, Doellinger C, Ebert L, Hummel M, Linde J, Prokosch HU, et al. Journal article Whither systems medicine? (2018) Apweiler R, Beissbarth T, Berthold MR, Bluethgen N, Burmeister Y, Dammann O, Deutsch A, et al. Journal article Neuromuscular Side Effects of Immune Checkpoint Inhibitors (2018) Moreira A, Loquai C, Knauss S, Gutzmer R, Dimitriou F, Meier F, Heppt M, et al. Conference contribution From relative to absolute treatment outcomes-Correlation of PASI 90 and PASI <= 2 in three clinical trials with secukinumab (2018) Reich K, Bachhuber T, Melzer N, Sieder C, Sticherling M Conference contribution